Paul V. Goode
President and Chief Operating Officer
Paul is a highly accomplished medical device professional with extensive experience in all areas of operations and product development, from initial concept to global commercialization. During his over twenty-year medical device career, Paul has spent considerable time working with innovative diabetes management technologies, including as Vice President of R&D at MetaCure, a neurostimulator device for Type 2 diabetes, Director of Engineering and Algorithm Development at DexCom, a global continuous glucose monitoring company and, as Senior Engineer at MiniMed, Inc., maker of integrated insulin pump and continuous glucose sensor systems, prior to its acquisition by Medtronic.
Paul received his BS, MS and PhD degrees from North Carolina State University, and is a named inventor on over 150 issued patents, including over 100 relating to DexCom’s continuous glucose sensing technology.
General Manager and VP Products
Erez brings 15 years of exceptional product management and leadership experience developing rapid growth strategies for medical device companies. Erez joins Integrity from 3D Systems Healthcare, a NASDAQ-listed 3D printing and digital manufacturing company where he spent 6 years in senior roles, including as Head of Global Market Development. In this role, Erez led all medical 3D printing and VR software solutions, designing the go-to-market strategy and overseeing global market development and expansion, as well as leading the product sales and growth at Point-of-Care. Previously, and until its acquisition by 3D Systems, Erez was leading the clinical application product portfolio at Simbionix, a leader in 3D virtual reality surgical simulation and training where he was responsible for the positioning and launch of their flagship patient-specific simulation product line. Prior to that, Erez held senior positions at Paieon Medical where he spearheaded the commercialization of the company’s cardiac catheterization real-time navigation system and led the company through ISO certification and product applications to FDA, CE and Health Canada.
He holds a B.Tech degree in Industrial Engineering from Shenkar College of Engineering and Design, and an M.B.A from Bar-Ilan University.
Chief Technology Officer
Shalom Shushan has over 20 years of leadership experience in technology and product development, and extensive experience in sensor technologies, machine learning, algorithm design, and product portfolio strategy. He also has key technical expertise in consumer, safety, and medical device technologies, including a variety of health-related wearables. Shushan’s leadership experience ranges from leading large international and cross-functional teams in various locations to working with and building emerging technology companies, including a medical device startup he founded. Most recently, Shushan was VP of Research and Development at Crow Technologies, Ltd. for 8 years where he drove the technical vision and strategy and was responsible for the development and implementation of the IoT, smart home and telemedicine platforms. Shalom Shushan was previously the co-founder and CEO of Nayos Ltd., a privately held integrated solutions company, and after its merger with Bio-Guard, CEO and CTO of Bio-Guard.
Shalom Shushan holds a Bachelor of Science degree in electrical and computer engineering with a specialization in signal and image processing from Ben-Gurion University.
Chief Financial Officer
Jolie Kahn has an extensive background in corporate finance and corporate and securities law. She has been the proprietor of Jolie Kahn, Esq. since 2002. Ms. Kahn has also acted in various corporate finance roles, including extensive involvement of preparation of periodic filings and financial statements and playing an integral part in public company audits. She also works with companies and hedge funds in complex transactions involving the structuring and negotiation of multi-million-dollar debt and equity financings, mergers, and acquisitions. Ms. Kahn has practiced law in the areas of corporate finance, mergers & acquisitions, reverse mergers, and general corporate, banking, and real estate matters. She represents both public and private companies, hedge funds, and other institutional investors in their role as investors in public companies.
She graduated from Cornell University with a Bachelor of Arts Degree in Government Relations and from The Benjamin N. Cardozo School of Law with a J.D., magna cum laude.